LENSAR Stock (NASDAQ:LNSR)

Revenue Ownership Financials Chart Transcripts

Previous Close

$7.20

52W Range

$2.10 - $7.96

50D Avg

$5.28

200D Avg

$4.49

Market Cap

$82.23M

Avg Vol (3M)

$32.19K

Beta

0.58

Div Yield

-

LNSR Company Profile

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

130

IPO Date

Oct 02, 2020

Website

LNSR Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 23	Dec 22	Dec 21
Product	$31.64M	$25.96M	$26.25M
Service	$4.07M	$3.48M	$3.25M

Fiscal year ends in Dec 23 | Currency in USD

LNSR Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$42.16M	$35.36M	$34.46M
Operating Income	$-11.13M	$-20.18M	$-19.65M
Net Income	$-14.38M	$-19.65M	$-19.65M
EBITDA	$-11.13M	$-19.03M	$-18.36M
Basic EPS	$-1.31	$-1.93	$-2.10
Diluted EPS	$-1.31	$-1.93	$-2.10

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q3 24Nov 09, 24 | 1:16 AM

Q1 24May 09, 24 | 12:00 AM

Q4 23Mar 04, 24 | 10:36 AM

Peer Comparison

Ticker	Company
AIMD	Ainos, Inc.
OFIX	Orthofix Medical Inc.
SGHT	Sight Sciences, Inc.
SSKN	STRATA Skin Sciences, Inc.
LUNG	Pulmonx Corporation
IRIX	IRIDEX Corporation
NPCE	NeuroPace, Inc.
SRDX	Surmodics, Inc.
AZYO	Elutia Inc.
SIEN	Sientra, Inc.
AXGN	AxoGen, Inc.
RXST	RxSight, Inc.